Here’s our Monday post for T1 Diabetes Cure- Global Headquarters. Enjoy!
Happy Monday!
Today we are going to be talking about our latest report, “Shrinking Funding of Type 1 Cure Research By the Four Major Non-Profits”, which takes a look at cure research funding trends over the last 4 years.
JDCA compiled information reveals that combined annual funding of type 1 research grants by the four major non-profits decreased by 44% from 2008-2011. In 2008, cure research allocations were $138 million and declined every year to $77 million in 2011.
Type 1 cure research spending as a percentage of the combined research grants decreased from an estimated 56% in 2008 to 41% in 2011. This means that in 2008 nearly six out of every ten research dollars were spent on a type 1 cure, whereas in 2011 that number decreased to only four out of every ten dollars.
Source: Charity and Foundation data and JDCA estimates. Information sources for the graphs include the following: JDRF: Foundation data for 2008-11 supplemented by JDCA estimate for 2011. DRIF: Foundation data for 2008-11. ADA: Charity data for 2010 and JDCA estimates for the other three years that assume an identical division between type 1 and 2 research; and within type 1, the same division between cure/glucose control/complications that was experienced in 2010. Joslin: JDCA estimates for all years 2008-11. Assumes that the Joslin-supplied division between type 1 and type 2 of 40/60 for 2010 is applied to the other years 2008, 2009, and 2011. Also assumes that the division of type 1 research for all years between cure/glucose control/complications is 1/3 for each.
It is important to note that in this analysis, JDCA numbers are based on cure research allocations as defined by the individual charities. This includes prevention research and some other research areas that the JDCA does not consider to be cure research.
Why has type 1 cure research spending declined?
The priority of some of the charities has moved away from cure over the past 4 years.
Charity Breakdown
– JDRF experienced a dramatic decrease in its allocation to cure research grants from 72% to 52% from 2008-11
– DRIF has the highest and steadiest allocation at 100%, as it states that all of its research funding is directed to cure ?research
– Both the ADA and Joslin have remained relatively steady, however, their percentages are low when compared with the DRIF or JDRF
Type 1 cure trends are heavily influenced by JDRF because they are the largest organization with robust fundraising initiatives and passionate volunteers and donors. They fund the most research and as a result have a significant effect on the community. From 2008 to 2011, their allocations to cure research grants decreased by 20 percentage points from 72% to 52%.
Source: JDRF Research Funding Fact Sheets for 2008-2011 including JDCA estimates for 2011. JDCA estimates that cure research grants were $60 million in 2011. This is based on total research expenditures of $116 million, which includes $22.8 million of funding associated with the Canadian government program.
Source: Charity and Foundation data and JDCA estimates (References are the same as the first graph in this blog)
Conclusion
The analysis in this report indicates that cure research is a declining priority for a majority of the type 1 diabetes charities. We believe that donors who give for the purpose of a cure should be aware of this trend when they make contributions.
Please email us at info@thejdca.org with any questions.
Cara Murphy
Senior Associate Editor
info@thejdca.org
